Community-acquired pneumonia briefly about the main. What is important to know to the physician. Based on the materials of the Russian National Congress «Man and Drug» and the III Pulmonology Summit
Recently more and more cases of viral community-acquired pneumonia have been recorded. Laboratory markers (C-reactive protein, procalcitonin) can help diagnose this disease and determine its prognosis. When choosing an antimicrobial drug, data on antibiotic resistance, the presence of concomitant di...
Saved in:
Main Author: | Yu. V. Evsutina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Open Systems Publication
2021-06-01
|
Series: | Лечащий Врач |
Subjects: | |
Online Access: | https://journal.lvrach.ru/jour/article/view/268 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Community-Acquired Pneumonia in Children Caused by Pneumococci of MLSB- and M-Phenotype: Clinical Cases
by: Natalya A. Ilenkova, et al.
Published: (2017-06-01) -
Novelties in the treatment of community-acquired and hospital-acquired pneumonia
by: Matteo Bassetti, et al.
Published: (2025-04-01) -
Antibiotic Therapy of Severe Community-Acquired Pneumonia
by: O. V. Molchanova, et al.
Published: (2020-05-01) -
Antibiotic Therapy of Mild Community-Acquired Pneumonia in Inpatients
by: O. V. Molchanova, et al.
Published: (2020-05-01) -
Optimizing antibiotic therapy of group IV community-acquired pneumonia patients.
by: Ya. O. Dziublyk
Published: (2014-06-01)